doi: 10.1126/scitranslmed.aah4477 Summary Keywords metabolic syndrome, atherosclerotic cardiovascular disease, hypertension, endothelial dysfunction, platelet hyperactivity Citation Das D, Shruthi NR, Banerjee A, Jothimani G, Duttaroy AK and Pathak S (2023) Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies
Route of Administration BPC-157 can be given subcutaneously, intramuscularly, orally, or sublingually depending on the clinical scenario and jurisdiction
GLP-1s, which have been used for years to treat Type 2 diabetes, have gained widespread attention as a way to lose weight and reduce obesity-related conditions and their long-term costs
I took 2 tablets in the morning, midday (before my workout) and right before I sleep
Researchers often wonder if they added water correctly or whether their solution is stable